3 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 3 | Unknown 3 |
Follow LifeTime Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia beta alethine - Lymphoma | Phase 1 / Phase 2 | Unknown | LifeTime Pharmaceuticals | 2002-03-01 | 2013-12-18 | |
| Beta Alethine in Treating Patients With Low-Grade Lymphoma beta alethine - Lymphoma | Phase 1 / Phase 2 | Unknown | LifeTime Pharmaceuticals | 2000-08-01 | 2013-12-18 | |
| Beta Alethine in Treating Patients With Myeloma beta alethine - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 1 / Phase 2 | Unknown | LifeTime Pharmaceuticals | 2000-08-01 | 2013-12-18 |
Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Precancerous Conditions (1) · Waldenstrom Macroglobulinemia (1)
alethine (3)
United States (3)